C2N Diagnostics

Overview

C2N Diagnostics is a specialty molecular diagnostics company dedicated to improving the early diagnosis and treatment of Alzheimer's disease and related neurodegenerative disorders. Founded by scientists from Washington University School of Medicine and LifeTech Research, the company operates a CLIA-certified laboratory in St. Louis, Missouri.

The organization utilizes advanced high-resolution mass spectrometry to identify and quantify protein biomarkers in blood, which are essential for diagnosing and monitoring brain disorders. Their flagship product, the PrecivityAD™ blood test, detects brain amyloid, a key indicator of Alzheimer's disease, and is available across most of the U.S., as well as holding a CE Mark in the European Union. The company is also pursuing FDA approval to further enhance accessibility of this test. C2N Diagnostics supports clinical decision-making, enhances clinical trial efficiency, and partners with pharmaceutical firms and academic institutions on research to advance Alzheimer's research and treatment worldwide.

Basic Information

Contact Details

• Phone: +1 877-226-3424
• Website: c2n.com
• LinkedIn: linkedin.com/company/c2n-diagnostics

Key Focus Areas & Initiatives

• Biotechnology research
• Biomarker technology
• Clinical research
• Diagnostic assay development
• Alzheimer's biomarker assays
• Neurodegenerative disease testing
• Blood test for brain amyloid
• Patient care
• Medical laboratories
• Global diagnostic partnerships
• Alzheimer's disease biomarkers
• Biomarker detection technology
• Neurodegeneration biomarkers
• Liquid biopsy technology
• Clinical research collaborations
• Healthcare
• Biomarker measurement
• Biomarker validation
• Decentralized testing
• Neurodegenerative disease biomarkers
• Biomarker discovery
• Biomarker quantification platforms
• Blood amyloid detection
• Clinical biomarker validation
• Liquid biopsy for neurodegeneration
• Phosphorylated tau biomarkers
• Neurodegenerative biomarker assay
• Biomarker validation in clinical trials
• Alzheimer's disease detection
• Biomarker development
• Biomarker detection in neurodegenerative diseases
• Biomarker quantification in plasma
• Clinical decision support
• Regulatory compliance
• Blood-based biomarkers
• Plasma tau biomarkers
• Clinical laboratory diagnostics
• Biomarker validation for treatment monitoring
• Biomarker assay development for neurodegeneration
• Diagnostic assay validation
• Biomarker research tools
• Biomarker assays
• Biomarker analysis techniques
• Biomarker measurement techniques
• Neurodegenerative biomarker research
• Pharmaceuticals
• Biomarker platform for neurodegeneration
• Biomarker validation studies
• Mass spectrometry
• Clinical laboratory services
• Healthcare technology
• Clinical laboratory
• Clinical decision-making
• Molecular diagnostics
• Clinical trial support
• Early detection
• Clinical trial biomarkers
• Biomarker validation techniques
• Biomarker platform
• Biomarker testing
• Neurodegeneration detection
• Amyloid beta ratios
• Mass spectrometry-based biomarker assay
• Biomarker assay automation
• Medical and diagnostic laboratories
• Early detection of Alzheimer's
• Biomarker research
• Biomarker services
• Treatment monitoring
• Biomarker analysis platforms
• Alzheimer's diagnosis
• Alzheimer's disease management
• Liquid chromatography-tandem mass spectrometry
• Diagnostic innovation
• Biomarker discovery in Alzheimer's
• Biomarker detection methods
• Biomarker platform technology
• Alzheimer's disease diagnosis
• Biomarker assay for early diagnosis
• Diagnostic platform technology
• Biotechnology
• High-resolution mass spectrometry
• Diagnostic test commercialization
• Alzheimer's disease
• Neurodegeneration
• Blood tests
• Precivity tests
• Biomarkers
• Diagnostic tools
• Amyloid plaques
• Caregiver support
• Clinical trials
• FDA approval
• Biopharmaceutical collaboration
• Proteins
• Liquid chromatography
• Diagnosis accuracy
• Minimally invasive tests
• Patient management
• Cognitive impairment
• Brain health
• Neuroimaging
• Epidemiological studies
• Genetic counseling
• Clinical performance
• Medical management
• Collaborative research
• Protein quantification
• Public health
• Early diagnosis
• Novel diagnostics
• Laboratory services
• Diagnostic accuracy
• Research studies
• Clinical utility
• Test development
• Plasma biomarkers
• Treatment evaluation
• Healthcare providers
• Clinical validation
• Personalized medicine
• Research innovation
• Distribution
• Health care
• Health, wellness & fitness
• Hospital & health care
• Medical & diagnostic laboratories
• Medical practice

Technologies Used

• Mailchimp Mandrill
• Microsoft Office 365
• Mobile Friendly
• Outlook
• Remote
• Salesforce
• Salesforce Service Cloud
• Squarespace ECommerce
• Typekit
• YouTube